Novartis India Limited (NSE:NOVARTIND)
India · Delayed Price · Currency is INR 2,005.20
-22.20 (-1.10%)
Sep 24, 2026, 11:10 AM IST
Novartis India Market Cap
Novartis India has a market cap or net worth of 50.04 billion as of September 23, 2026. Its market cap has increased by 126.40% in one year.
Market Cap
50.04B
Enterprise Value
43.40B
Revenue
3.71B
Ranking
n/a
PE Ratio
51.19
Stock Price
2,005.20
ChartMarket Cap Chart
Since April 14, 1999, Novartis India's market cap has increased from 12.59B to 50.04B, an increase of 297.64%. That is a compound annual growth rate of 5.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 50.04B | 160.19% |
| Dec 31, 2025 | 19.23B | -15.31% |
| Dec 31, 2024 | 22.71B | 18.95% |
| Dec 29, 2023 | 19.09B | 14.56% |
| Dec 30, 2022 | 16.67B | -12.94% |
| Dec 31, 2021 | 19.14B | 13.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Strides Pharma Science | 112.75B |
| Aarti Pharmalabs | 85.25B |
| Innova Captab | 74.26B |
| Sun Pharma Advanced Research Company | 66.74B |
| Orchid Pharma | 55.89B |
| RPG Life Sciences | 50.04B |
| Ind-Swift Laboratories | 35.22B |
| Solara Active Pharma Sciences | 34.88B |